@SpotSense

Making healthcare simple!

 Bengaluru, India
spotsense.in
Joined February 2018
  • Tweets111
  • Following250
  • Followers127
6Media
SpotSense retweeted
C-CAMP
@CCAMP_India14 Jun 2022
A long supported innovation for #NeonatalHealth gets to the field & what better place to start than an underserved tribal community? CCAMP supported neonatal sepsis monitoring tech gets deployed in tribal majority Sargur, Karnataka in partnership with @SELCOFoundation @SpotSense
1
7
10
SpotSense retweeted
C-CAMP
@CCAMP_India15 Jun 2022
CCAMP CEO-Dir Dr @Taslimarif gives shout out to 3 deep science startups from CCAMP who are scaling succesfully in their "Method to Madness" @Blackfroghealth @Bioprimeagri @Spotsense Catch the conversation youtu.be/KRUw30aGrJg #IndiaAtVivaTech @VivaTech
4
5
The Lancet Commission on #diagnostics: transforming access to diagnostics in #LMICs launched today! A great step in the right direction #DiagnosticCommission @DiagnosticsCom thelancet.com/commissions/di…
FIND
@FINDdx7 Oct 2021
"We need to get greater recognition of the crucial role that #testing plays in pandemic response. We need to drive #diagnostics up the agenda in terms of visibility and funding." - @PeterASands, @GlobalFund #DiagnosticsCommission #DiagnosisForAll @DiagnosticsCom
2
5
DYK that even when new #antibiotics are approved, they rarely target priority #drugresistant bacteria and are only registered for use in a small number of countries? Find out how you can support our life-saving work right here: resist-resistance.gardp.org/ #ResistResistance
4
11
#COVID19 interventions in resource-limited settings need to be affordable, available, and adapted to the health care systems and the populations they are serving. #COVID19crc @TheLancet bit.ly/2UChxlj
5
1
16
Replying to @MoHFW_INDIA
@MoHFW_INDIA @ICMRDELHI Need your intervention to control prices for Rapid Kits. Rs. 200-300 kits are now costing Rs 1000 - pls look into this else the benefit of using Rapid Kits to quickly test millions of citizens at scale becomes economically impossible. @StartupsvsCovid
7
1
4
Lack of massive testing is where we will fail in ending this outbreak. What are we waiting for? #COVID #coronavirusindia
This Post is from an account that no longer exists. Learn more
2
1
Where are our COVID19 positive patients? We need at scale screenings now! @anuacharya @PrinSciAdvGoI
Kiran Mazumdar-Shaw
@kiranshaw25 Mar 2020
Association of Biotechnology Led Enterprises - very good piece by ⁦@anuacharya⁩ ableindia.in/news/details/74…
2
Just to re-up, diagnostic capacity is not a new issue. It's not just a COVID problem; it's a TB, antibiotic resistance, malaria, HIV, sepsis, cold problem forbes.com/sites/madhukarpai… @paimadhu
19
2
21
"If you look at the Coronavirus #COVIDー19 conversation now, containment without providing care doesn’t work well. If you're not concerned with treatment, this is a colonial recipe for mistrust." -Paul Farmer Co-founder of Partners in Health, and Duke Trustee @DukeGHI @DukeU
4
1
22
Health tools developed in wealthy countries can take 𝙙𝙚𝙘𝙖𝙙𝙚𝙨 to reach the people who need them most. By investing in home-grown innovation, we can accelerate and expand the reach of lifesaving breakthroughs 💉💊🔬. gates.ly/39WoS3U
6
51
5
137
At the very onset of behavioural research for #AntibioticResistance stewardship we should perhaps curate stories of what hasn’t worked. Including the interventional methodology and failure nodes. This seems like a good step in that direction.
Sian Williams@SianLWilliams926 Feb 2020
Last year @Wellcome_AMR had a go at a project to tackle overuse and misuse of #antibiotics in India and Kenya. It didn't work out the way we hoped... Here are 5 things we learned – hope also useful to others using #BehaviouralInsights to create change 👇 wellcome.ac.uk/news/5-things…
This is a great loss to nation! Dr. M K Bhan was one of the greatest inspirations to us. Our prayers are with his family. May he rest in peace.
Principal Scientific Adviser, Govt. of India
@PrinSciAdvGoI26 Jan 2020
Dr. M. K. Bhan passed away a short while ago. A great pediatrician and humanist, foremost. A clinician scientist who pioneered a rotavirus vaccine, excellent science administrator, leader of complex missions in health and nutrition, a dear friend. Too sudden and too soon.
We are deeply saddened to learn the news that Dr. Peter Salama, epidemiologist and @WHO's Executive Director of the Division of Universal Health Coverage, has passed. Our thoughts are with his family and our friends and partners at WHO at this time.
1
3
11
Antibiotic resistance has become a serious threat to human health around the world. We caught up with #AMR #diagnostic innovators and clinicians about their thoughts on the impact of #AMR on healthcare and the people facing these issues in India. youtube.com/watch?v=EfNUsr0a…
27
6
38
Sepsis is a leading cause of death in children under 5 & threatens achievement of SDG3. A new Lancet report shows sepsis deaths twice as high as previously thought. #GARDP is working with partners to develop new & improved treatments for neonatal sepsis: bit.ly/2FUefls
The Lancet
@TheLancet16 Jan 2020
Presenting now #CCR20—First #GBDStudy estimates of #sepsis incident cases (49 million in 2017) & mortality (11 million in 2017) are twice that thought previously; highlighting need for greater prevention and treatment especially in sub-Saharan Africa @IHME hubs.ly/H0mBnhv0
4
7
Heartiest congratulations @ashokaiims !
Ashok Deorari MD FAMS@ashokaiims23 Dec 2019
Honoured to take over as President NNF of India 2020 from Dr V.P. Goswami, organisation with 8500 members. Aiming to set high academic standards for Gen Z ; providing #quality healthcare for newborns with partnership with @MoHFW_INDIA and neonatal nurses @iapindia @Nnfindia1
Do join us, tomorrow 26th Nov!!
Longitude Prize on ALS@longitude_prize25 Nov 2019
Remember to join the @gardp_amr #REVIVE webinar on innovation in #AMR POC diagnostics for #sepsis & bloodstream infections, tomorrow morning from 8.30am GMT with @CarolinePurslow @SpotSense @BachmannTill xitter.cf/gardp_amr/status/11942…
1
Join us on 26th Nov for the #REVIVE webinar on Innovations in point-of-care diagnostics for sepsis and bloodstream infections. #Sepsis #diagnostics
Global Antibiotic R&D Partnership (GARDP)
@gardp_amr12 Nov 2019
Amrita Sukrity is from @SpotSense, a team currently working to develop a low-cost diagnostics for neonatal #sepsis in the @longitudeprize to #StopSuperbugs. Join her & our other esteemed speakers in our next #REVIVE webinar: bit.ly/2pfeN0w #WakeUpToAMR
1
Load more